Response of liver metastases to preoperative radiochemotherapy in patients with locally advanced rectal cancer and resectable synchronous liver metastases

Surgery (United States)

Volumn 154, Issue 3, 2013, Pages 528-535

  Manceau, Gilles ^a   Brouquet, Antoine ^b   Bachet, Jean Baptiste ^a   Penna, Christophe ^b   El Hajjam, Mostafa ^a   Rougier, Philippe ^a   Nordlinger, Bernard ^a   Benoist, Stephane ^b  

^a HÔPITAL AMBROISE PARÉ   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER SURGERY; CATHETER INFECTION; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; FEMALE; HEMATOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEUS; LIVER METASTASIS; LIVER RESECTION; LOW DRUG DOSE; MALE; NEUROPATHY; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE DELIRIUM; PREOPERATIVE CARE; PRIORITY JOURNAL; RECTUM CANCER; RECTUM SURGERY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SURGICAL INFECTION; TREATMENT RESPONSE; URINARY TRACT INFECTION; URINE RETENTION;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY; DISEASE PROGRESSION; FEMALE; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RECTAL NEOPLASMS;

EID: 84883226242     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2013.02.010     Document Type: Article

References (27)

1. D.C. McMillan, and C.S. McArdle Epidemiology of colorectal liver metastases Surg Oncol 16 2007 3 5
2. J.F. Bosset, L. Collette, G. Calais, L. Mineur, P. Maingon, and L. Radosevic-Jelic Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 2006 1114 1123
3. J.P. Gérard, T. Conroy, F. Bonnetain, O. Bouché, O. Chapet, and M.T. Closon-Dejardin Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203 J Clin Oncol 24 2006 4620 4625
4. R. Sauer, H. Becker, W. Hohenberger, C. Rödel, C. Wittekind, and R. Fietkau Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
5. B. Nordlinger, H. Sorbye, B. Glimelius, G.J. Poston, P.M. Schlag, and P. Rougier Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 371 2008 1007 1016
6. S. Benoist [Recommendations for clinical pice. Therapeutic choices for rectal cancer. How should rectal cancers with synchronous metastases be managed?] Gastroenterol Clin Biol 1 2007 S75 S80
7. S. Roman, J.C. Cenni, P. Roy, B. Pujol, B. Napoleon, and O. Keriven-Souquet Value of rectal ultrasound in predicting staging and outcome in patients with rectal adenocarcinoma Dis Colon Rectum 47 2004 1323 1330
8. J.P. Gérard, D. Azria, S. Gourgou-Bourgade, I. Martel-Laffay, C. Hennequin, and P.L. Etienne Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2 J Clin Oncol 28 2010 1638 1644
9. P. Therasse, S.G. Arbuck, E.A. Eisenhauer, J. Wanders, R.S. Kaplan, and L. Rubinstein New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
10. R.J. Heald, and R.D. Ryall Recurrence and survival after total mesorectal excision for rectal cancer Lancet 1 1986 1479 1482
11. D. Dindo, N. Demartines, and P.A. Clavien Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 2004 205 213
12. I.D. Nagtegaal, C.J. van de Velde, E. van der Worp, E. Kapiteijn, P. Quirke, and J.H. van Krieken Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control J Clin Oncol 20 2002 1729 1734
13. C. Rödel, P. Martus, T. Papadoupolos, L. Füzesi, M. Klimpfinger, and R. Fietkau Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer J Clin Oncol 23 2005 8688 8696
14. D.G. Blazer 3rd, Y. Kishi, D.M. Maru, S. Kopetz, Y.S. Chun, and M.J. Overman Pathological response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases J Clin Oncol 26 2008 5344 5351
15. A. de Gramont, A. Figer, M. Seymour, M. Homerin, A. Hmissi, and J. Cassidy Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2000 2938 2947
16. R.C. Auer, R.R. White, N.E. Kemeny, L.H. Schwartz, J. Shia, and L.H. Blumgart Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy Cancer 116 2010 1502 1509
17. B. Angliviel, S. Benoist, C. Penna, M. El Hajjam, S. Chagnon, and C. Julié Impact of chemotherapy on the accuracy of computed tomography scan for the evaluation of colorectal liver metastases Ann Surg Oncol 16 2009 1247 1253
18. C. Aschele, L. Cionini, S. Lonardi, C. Pinto, S. Cordio, and G. Rosati Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial J Clin Oncol 29 2011 2773 2780
19. C. Rödel, T. Liersch, H. Becker, R. Fietkau, W. Hohenberger, and T. Hothorn Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial Lancet Oncol 13 2012 679 687
20. M.J. Gosens, R.A. Klaassen, I. Tan-Go, H.J. Rutten, H. Martijn, and A.J. van den Brule Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma Clin Cancer Res 13 2007 6617 6623
21. M. Wieser, S. Sauerland, D. Arnold, W. Schmiegel, and A. Reinacher-Schick Peri-operative chemotherapy for the treatment of resectable liver metastases from colorectal cancer: a systematic review and meta-analysis of randomized trials BMC Cancer 10 2010 309
22. B. Gruenberger, W. Scheithauer, R. Punzengruber, C. Zielinski, D. Tamandl, and T. Gruenberger Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases BMC Cancer 8 2008 120
23. G. Mentha, P.E. Majno, A. Andres, L. Rubbia-Brandt, P. Morel, and A.D. Roth Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary Br J Surg 93 2006 872 878
24. A. Brouquet, M.M. Mortenson, J.N. Vauthey, M.A. Rodriguez-Bigas, M.J. Overman, and G.J. Chang Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg 210 2010 934 941
25. A.E. van der Pool, J.H. de Wilt, Z.S. Lalmahomed, A.M. Eggermont, J.N. Ijzermans, and C. Verhoef Optimizing the outcome of surgery in patients with rectal cancer and synchronous liver metastases Br J Surg 97 2010 383 390
26. C. Fernández-Martos, C. Pericay, J. Aparicio, A. Salud, M. Safont, and B. Massuti Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo Cancer de Recto 3 Study J Clin Oncol 28 2010 859 865
27. Y.J. Chua, Y. Barbachano, D. Cunningham, J.R. Oates, G. Brown, and A. Wotherspoon Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial Lancet Oncol 11 2010 241 248